secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stimcell Energetics Inc. (STME)
CIK:        0001493712
Form:       8-K
Filed at:   2022-10-18T23:59:59+00:00
Accession:  0001393905-22-000425
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cell MedX gets BCSC cease trade order, grants security over eBalance IP on ~$539k loan
--------------------------------------------------------------------------------

- BCSC issued cease trade order on Oct 11, 2022 for failing to file annual financial statements due to insufficient audit funds.
- Consolidated ~$539,325 in loans from major shareholder Richard Jeffs; granted security interest over eBalance Technology and IP on default.
- Loans remain due on demand with 6% annual interest compounded monthly; no revenue from eBalance Systems yet.
- Company cannot assure it will raise necessary funding to remedy filing defaults or complete the audit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493712/000139390522000425/0001393905-22-000425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493712/000139390522000425/cmxc-20221011.htm
  HTML page:      https://secwatch.observer/filing/0001393905-22-000425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer